BIIB vs DIBS · P/E 21, rev $9.89B vs rev $45.7M
Biogen Inc (BIIB) versus 1Stdibs.Com Inc (DIBS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
1Stdibs.Com Inc (DIBS) is a internet retail company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported DIBS revenue for 2026-06-30 was $45.7M. Net income was -$3.2M. DIBS currently screens at market cap $101.0M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. DIBS currently screens at market cap $101.0M.
Not investment advice. Open the BIIB and DIBS stock pages for the full models.
Not investment advice.